Literature DB >> 17697433

Graves' disease, with and without nodules, and the risk of thyroid carcinoma.

Y Erbil1, U Barbaros, N Ozbey, Y Kapran, M Tükenmez, A Bozbora, S Ozarmağan.   

Abstract

OBJECTIVE: Thyroid nodules are frequently present in Graves' disease. The aim of this study was to evaluate the risk of thyroid carcinoma in Graves' disease patients, with and without ultrasonographically identified nodules, who subsequently underwent surgical treatment.
DESIGN: The study group included 150 consecutive patients with diagnosed Graves' disease who subsequently underwent surgery.
SUBJECTS: The patients were divided into two groups according to whether the pre-operative ultrasound scan showed diffuse parenchyma (group one; n = 70) or nodules (group two; n = 80).
RESULTS: Of the 150 patients, 18 (12 per cent) were found to have papillary thyroid carcinoma. Papillary carcinoma was found in seven patients (10 per cent) in group one and in 11 patients (1.7 per cent) in group two. After evaluating the overall groups, the incidence of carcinoma in the parenchyma outside a nodule was 67 per cent, whereas the incidence of carcinoma in a nodule was 33 per cent.
CONCLUSION: Carcinoma can occur in Graves' disease patients without nodules, and the absence of nodules on ultrasonographic examination does not reduce the risk of malignancy.

Entities:  

Mesh:

Year:  2007        PMID: 17697433     DOI: 10.1017/S0022215107000448

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

1.  Thyroid carcinoma in patients with Graves' disease: an institutional experience.

Authors:  Shuanzeng Wei; Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

2.  Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China.

Authors:  Rong Zeng; Tao Shou; Kun-Xian Yang; Tao Shen; Jin-Ping Zhang; Rong-Xia Zuo; Yong-Qing Zheng; Xin-Ming Yan
Journal:  Ther Clin Risk Manag       Date:  2016-06-30       Impact factor: 2.423

3.  [Association of hyperthyroidism with differentiated thyroid cancer].

Authors:  Nassim Essabah Haraj; Hayat Ahandar; Siham El Aziz; Asma Chadli
Journal:  Pan Afr Med J       Date:  2016-05-06

4.  Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.

Authors:  Jee Hee Yoon; Meihua Jin; Mijin Kim; A Ram Hong; Hee Kyung Kim; Bo Hyun Kim; Won Bae Kim; Young Kee Shong; Min Ji Jeon; Ho-Cheol Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2021-11-26

5.  Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases.

Authors:  Priscila Carneiro Moreira Lima; Arnaldo Moura Neto; Marcos Antonio Tambascia; Denise Engelbrecht Zantut Wittmann
Journal:  ISRN Endocrinol       Date:  2013-05-25

6.  A Rare Presentation of Autonomously Functioning Papillary Thyroid Cancer: Malignancy in Marine-Lenhart Syndrome Nodule.

Authors:  Mehmet Uludag; Nurcihan Aygun; Alper Ozel; Feyza Yener Ozturk; Rabia Karasu; Banu Yilmaz Ozguven; Bulent Citgez; Mehmet Mihmanli; Adnan Isgor
Journal:  Case Rep Surg       Date:  2016-03-27

7.  Frequency of thyroid nodules and thyroid cancer in thyroidectomized patients with Graves' disease.

Authors:  Caglar Keskin; Mustafa Sahin; Rovshan Hasanov; Berna Imge Aydogan; Ozgur Demir; Rıfat Emral; Sevim Gullu; Murat Faik Erdogan; Vedia Gedik; Ali Riza Uysal; Nilgun Baskal; Demet Corapcioglu
Journal:  Arch Med Sci       Date:  2019-01-11       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.